Literature DB >> 7536672

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

M Tanaka1, T Suda, T Takahashi, S Nagata.   

Abstract

Fas is a type I membrane protein which mediates apoptosis. Fas ligand (FasL) is a 40 kDa type II membrane protein expressed in cytotoxic T cells upon activation that belongs to the tumor necrosis factor (TNF) family. Here, we found abundant cytotoxic activity against Fas-expressing cells in the supernatant of COS cells transfected with human FasL cDNA but not with murine FasL cDNA. Using a specific polyclonal antibody against a peptide in the extracellular region of human FasL, a protein of 26 kDa was detected in the supernatant of the COS cells. The signal sequence of granulocyte colony-stimulating factor was attached to the extracellular region of human FasL. COS cells transfected with the cDNA coding for the chimeric protein efficiently secreted the active soluble form of human FasL (sFasL). Chemical crosslinking and gel filtration analysis suggested that human sFasL exists as a trimer. Human peripheral T cells activated with phorbol myristic acetate and ionomycin also produced functional sFasL, suggesting that human sFasL works as a pathological agent in systemic tissue injury.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536672      PMCID: PMC398190          DOI: 10.1002/j.1460-2075.1995.tb07096.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  53 in total

Review 1.  Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level.

Authors:  W Fiers
Journal:  FEBS Lett       Date:  1991-07-22       Impact factor: 4.124

2.  Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma.

Authors:  M J Androlewicz; J L Browning; C F Ware
Journal:  J Biol Chem       Date:  1992-02-05       Impact factor: 5.157

3.  Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.

Authors:  T Stalder; S Hahn; P Erb
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

Review 4.  The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.

Authors:  C A Smith; T Farrah; R G Goodwin
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

5.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

Authors:  N Itoh; S Yonehara; A Ishii; M Yonehara; S Mizushima; M Sameshima; A Hase; Y Seto; S Nagata
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

6.  Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

Authors:  F Leithäuser; J Dhein; G Mechtersheimer; K Koretz; S Brüderlein; C Henne; A Schmidt; K M Debatin; P H Krammer; P Möller
Journal:  Lab Invest       Date:  1993-10       Impact factor: 5.662

7.  The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution.

Authors:  M J Eck; M Ultsch; E Rinderknecht; A M de Vos; S R Sprang
Journal:  J Biol Chem       Date:  1992-02-05       Impact factor: 5.157

Review 8.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease.

Authors:  P L Cohen; R A Eisenberg
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

9.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

Authors:  T Takahashi; M Tanaka; C I Brannan; N A Jenkins; N G Copeland; T Suda; S Nagata
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

10.  Purification and characterization of the Fas-ligand that induces apoptosis.

Authors:  T Suda; S Nagata
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  111 in total

1.  T cell receptor-induced activation and apoptosis in cycling human T cells occur throughout the cell cycle.

Authors:  M Karas; T Z Zaks; J L Liu; D LeRoith
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

2.  Characterization of the expanded T cell population in infectious mononucleosis: apoptosis, expression of apoptosis-related genes, and Epstein-Barr virus (EBV) status.

Authors:  C S Verbeke; U Wenthe; W F Bergler; H Zentgraf
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

3.  Elevated serum-soluble Fas ligand in histiocytic necrotizing lymphadenitis.

Authors:  K Kato; K Ohshima; K Anzai; J Suzumiya; M Kikuchi
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

4.  Soluble Fas-ligand (sFasL) in human astrocytoma cyst fluid is cytotoxic to T-cells: another potential means of immune evasion.

Authors:  B Frankel; S L Longo; G W Canute
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

Review 5.  Death receptor signaling and autoimmunity.

Authors:  Richard M Siegel; Jagan Muppidi; Margaret Roberts; Melissa Porter; Zhengqi Wu
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

6.  Automated Analysis of Single-Molecule Photobleaching Data by Statistical Modeling of Spot Populations.

Authors:  Clarissa Liesche; Kristin S Grussmayer; Michael Ludwig; Stefan Wörz; Karl Rohr; Dirk-Peter Herten; Joël Beaudouin; Roland Eils
Journal:  Biophys J       Date:  2015-12-01       Impact factor: 4.033

7.  Cartilage-hair hypoplasia syndrome: increased apoptosis of T lymphocytes is associated with altered expression of Fas (CD95), FasL (CD95L), IAP, Bax, and Bcl2.

Authors:  L Yel; S Aggarwal; S Gupta
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

8.  Serum levels of soluble Fas ligand in patients with silicosis.

Authors:  A Tomokuni; T Otsuki; Y Isozaki; S Kita; H Ueki; M Kusaka; T Kishimoto; A Ueki
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

9.  Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL.

Authors:  C Raoul; E Buhler; C Sadeghi; A Jacquier; P Aebischer; B Pettmann; C E Henderson; G Haase
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 11.205

Review 10.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.